AlzChem Group AG

AlzChem Group AG puts new Creamino plant into operation

Trostberg, September 13, 2019 – AlzChem Group AG, a vertically integrated specialty chemicals supplier with leading market positions in select niche markets, officially commissioned its new Creamino plant at the Trostberg Chemical Park yesterday. The company has thus tripled its production capacity for this fast-growing feed additive from around 7,000 tons to around 21,000 tons.

DYHARD® Conference

25 members of the global DYHARD® Community from the U.S., Asia and Europe attended the 2nd DYHARD® World Sales Conference (DWSC) in Grassau close to Lake Chiemsee.

After presenting the respective local markets, the latest developments of the DYHARD® product portfolio were discussed: innovative technologies such as our DYHARD® fluid epoxy system for filament winding of composite pressure vessels, i.e. for hydrogen mobility. Our objective: TOGETHER FOR ONE VISION.

Creapure® – Creatine monohydrate of the highest quality and purity from Bavaria

For many years, the AlzChem Group has been producing creatine monohydrate under the brand name Creapure® in the heart of Bavaria, the Chiemgau region. Both professional and recreational athletes from all over the world rely on the purity and effectiveness of Creapure®. But what do we need creatine for? And why does it come from Trostberg?

 

Andreas Niedermaier becomes new CEO – Dr. Georg Weichselbaumer appointed to the Management Board effective July 1, 2019

Trostberg, June 3, 2019 – The Supervisory Board of AlzChem Group AG has decided to appoint Mr. Andreas Niedermaier (CFO) as the new CEO with effect from July 1, 2019, in view of the resignation of the current CEO Mr. Ulli Seibel as of December 31, 2019. In this function, Mr. Niedermaier will also be responsible for Investor Relations and Communications. Dr. Georg Weichselbaumer was newly appointed to the Management Board effective July 1, 2019. Dr.

AlzChem Group AG: Annual General Meeting approves dividend of EUR 0.09 per share

Trostberg, May 14, 2019 – At today's Annual General Meeting of AlzChem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, the shareholders present honored the successful business development and corporate strategy and expressed their confidence in the Management Board and Supervisory Board. All items on the agenda were resolved by a large majority in the interests of management, which included a dividend payment of EUR 0.09 per share and, among other things, a reverse stock split of 10 to 1.